A Phase 3 Prospective Multi-Center Single-Arm Open-Label Study to Evaluate VeraCept a Long-Acting Reversible Intrauterine Contraceptive for Contraceptive Efficacy Safety and Tolerability
Not Recruiting
18-45 years
Female
Phase
3
200 participants needed
1 Location
Brief description of study
A research study for woman of child bearing age or potential and interested in using an intrauterine device (IUD) for birth control for up to 5 years.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Contraceptive
-
Age: Between 18 Years - 45 Years
-
Gender: Female
Updated on
08 May 2024.
Study ID: 831931
